100 million Allogeneic Mesenchymal Human Stem Cells

DRUG2 trials

Sponsors

Joshua M Hare

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2Ischemic Heart Disease

Phase 1

Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects

CompletedNCT02886884

Joshua M HareDiabetes Mellitus, Type 2

Start: 2017-10-20End: 2020-09-03Updated: 2022-05-11

Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)

CompletedNCT04776239

Joshua M HareDiabetes Mellitus, Ischemic Heart Disease

Start: 2021-08-16End: 2025-08-26Updated: 2026-06-16

Related Papers

(228) Cell-Based Therapy Can Restore Erectile Function in Men with Type 2 Diabetes and Metabolic Syndrome by Promoting Angiogenesis and Endothelial Repair

The Journal of Sexual Medicine2024-02-01

The impact of cell-based therapy on female sexual dysfunction: a systematic review and meta-analysis.

2023-09-01

Effect of Stem Cell Infusion Therapy on Sexual Function in Women with Type 2 Diabetes and Metabolic Syndrome: Post-Hoc Analysis of Randomized Controlled Trials

The Journal of Sexual Medicine2022-07-26

85 Effect of Stem Cell Infusion Therapy on Sexual Function in Men and Women with Type 2 Diabetes and Metabolic Syndrome: Results from the ACESO & CERES Clinical Trials

The Journal of Sexual Medicine2022-04-01

Abstract 9813: A Randomized, Double Blind, Clinical Trial to Evaluate Safety and Efficacy of Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial Dysfunction in Diabetic Subjects (ACESO)

Circulation2021-11-16